Positive expression of SHMT2 was significantly correlated with TNM stage and lymph node metastasis, and elevated expression of SHMT2 resulted as an independent prognostic factor in patients with CRC. This evidence concerns the gene SHMT2 and metastatic malignant neoplasm in the lymph nodes.